ABAXIS INC Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2018 As of Mar 31, 2018	Q3 FY2018 As of Dec 31, 2017	Q2 FY2018 As of Sep 30, 2017	Q1 FY2018 As of Jun 30, 2017	Q4 FY2017 As of Mar 31, 2017	Q3 FY2017 As of Dec 31, 2016	Q2 FY2017 As of Sep 30, 2016	Q1 FY2017 As of Jun 30, 2016	Q4 FY2016 As of Mar 31, 2016	Q3 FY2016 As of Dec 31, 2015	Q2 FY2016 As of Sep 30, 2015	Q1 FY2016 As of Jun 30, 2015	Q4 FY2015 As of Mar 31, 2015	Q3 FY2015 As of Dec 31, 2014	Q2 FY2015 As of Sep 30, 2014	Q1 FY2015 As of Jun 30, 2014	Q4 FY2014 As of Mar 31, 2014	Q3 FY2014 As of Dec 31, 2013	Q2 FY2014 As of Sep 30, 2013	Q1 FY2014 As of Jun 30, 2013
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Receivables (net of allowances of $525 in 2018 and $272 in 2017)
Inventories
Prepaid expenses and other current assets
Net deferred tax assets, current
Current assets of discontinued operations
Total current assets
Long-term investments
Investment in unconsolidated affiliate
Investments in unconsolidated affiliates
Property and equipment, net
Intangible assets, net
Net deferred tax assets, non-current
Non-current assets of discontinued operations
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued payroll and related expenses
Accrued taxes
Current liabilities of discontinued operations
Other accrued liabilities
Deferred revenue
Warranty reserve
Total current liabilities
Non-current liabilities:
Deferred rent
Deferred revenue
Warranty reserve
Net deferred tax liabilities
Non-current liabilities of discontinued operations
Notes payable, less current portion
Other non-current liabilities
Total non-current liabilities

Total liabilities
Shareholders' equity:
Preferred stock, no par value: 5,000,000 shares authorized; no shares issued and outstanding in 2018 and 2017
Common stock, no par value: 35,000,000 shares authorized; 22,698,000 and 22,540,000 shares issued and outstanding in 2018 and 2017, respectively
Retained earnings
Accumulated other comprehensive loss
Total shareholders' equity
Total liabilities and shareholders' equity

Comments